Business

ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials

EU News WeekEU News Week
May 30, 2025 - 14:00
 0  0
ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
EU News Week
EU News Week

Related Posts

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

EU News Week Mar 21, 2025  0  0

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

EU News Week Mar 21, 2025  0  3

Factbox-What fighter jet programs does the US Air Force have?

Factbox-What fighter jet programs does the US Air Force...

EU News Week Mar 21, 2025  0  1

ZipRecruiter CTO Boris Shimanovsky sells $22,788 in stock

ZipRecruiter CTO Boris Shimanovsky sells $22,788 in stock

EU News Week Mar 21, 2025  0  0

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

EU News Week Mar 21, 2025  0  2

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

EU News Week Mar 21, 2025  0  0